Angelmicin B is a potently cytotoxic glycoside natural product isolated from the actinomycete Microbispora species. While the relative stereochemistry of this glycoside have been reported, the stereochemistry of the three sugars relative to the aglycone remains unassigned. The objectives of this proposal are three-fold: The first involves the synthesis of the hindered glycosyl acceptor segment of angelmicin B by way of a neighboring-group assisted oxocarbenium annulation cascade. Second, the enantioselective synthesis of the three deoxyglycosides found in angelmicin B will be performed. When both the glycosyl acceptor and the enantiopure monosaccharides are in hand, methodology for alpha- and beta- stereoselective glycosylations of hindered substrates will be established. Finally, stereochemical correlations between the model system and the natural product will be performed in order to determine the stereochemistry of the sugars relative to the aglycone. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM076818-02
Application #
7254688
Study Section
Special Emphasis Panel (ZRG1-F04A-D (20))
Program Officer
Fabian, Miles
Project Start
2006-07-01
Project End
2007-08-06
Budget Start
2007-07-01
Budget End
2007-08-06
Support Year
2
Fiscal Year
2007
Total Cost
$7,397
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037